ea0035eje1 | The European Journal of Endocrinology Prize Lecture | ECE2014
Fassnacht Martin
Adrenocortical carcinoma (ACC) is not only a rare and heterogeneous disease but also one of the most aggressive endocrine tumors. Despite significant advances in the last decade, its pathogenesis is still only incompletely understood and overall therapeutic means are unsatisfactory.During this lecture, we provide our personal view of the currently available treatment options and suggest the following research efforts that we consider timely and necessary...